inVentiv Health Completes Acquisition Financing
Date: 07/13/11
Cahill represented BofA Merrill Lynch, Citi, Jefferies, Credit Suisse, Deutsche Bank Securities and Wells Fargo Securities as joint book-running managers in the Rule 144A/Reg S offering of $390,000,000 of 10% Senior Notes due 2018 by inVentiv Health, Inc. to partially finance inVentiv's acquisition of PharmaNet Development Group.Cahill also represented Citibank as administrative agent for the amendment and restatement of inVentiv's $1,210,800,000 credit facility, including a $245,000,000 term B-3 loan and $30,000,000 of additional revolving commitments, also in connection with financing the acquisition.